Search Results
Oct 23, 2025, 09:00 ET New York Regional Diabetes Research Center Receives $10M Award from NIH
research, and faculty investigators developing new techniques and technologies that will enhance research progress. The grant (P30DK020541-50), titled "New York Regional Center for Diabetes Translation Research," was awarded by the National Institute of Diabetes and Digestive and Kidney
More news about: Albert Einstein College of Medicine
Oct 21, 2025, 14:33 ET Researchers Link Orphan Gene in SARS-CoV-2 Virus to More Severe Cases of COVID-19
This study was supported by the National Science Foundation award IOS 1546858, National Institutes of Health grants NIAID 2R01AI107301, NIDDK R01DK121072, R01GM133810 the American Heart Association, the Irma Hirschl Trust Research Award Scholar, Department of Defense grant W81XWH-21-1-0128, the Gates
More news about: Children's Hospital of Philadelphia
Oct 21, 2025, 01:38 ET Embla Medical hf: Interim Report Q3 2025
9:00 CET / 7:00 GMT / 3:00 ET.To actively participate in the telephone conference, please use the dial-in details provided below:DK: +45 78 76 84 90UK: +44 20 3769 6819US: +1 646 787 0157Participant access code: 274982The webcast will be available
More news about: Embla Medical hf.
Oct 21, 2025, 01:31 ET Embla Medical hf: Interim Report Q3 2025
9:00 CET / 7:00 GMT / 3:00 ET.To actively participate in the telephone conference, please use the dial-in details provided below:DK: +45 78 76 84 90UK: +44 20 3769 6819US: +1 646 787 0157Participant access code: 274982The webcast will be available
More news about: Embla Medical hf.
Oct 17, 2025, 17:39 ET FDA approves Novo Nordisk's oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event
Rybelsus® (oral semaglutide) [package insert]. Plainsboro, NJ: Novo Nordisk Inc. McGuire DK, Marx N, Mulvagh SL, et al. Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes.N Engl J Med. 2025;392(20):2001-2012.
More news about: Novo Nordisk
Oct 17, 2025, 17:15 ET FDA approves Novo Nordisk's oral semaglutide for cardiovascular (CV) risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event
References Rybelsus® (oral semaglutide) [package insert]. Plainsboro, NJ: Novo Nordisk Inc. McGuire DK, Marx N, Mulvagh SL, et al. Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes.N Engl J Med. 2025;392(20):2001-2012.
More news about: Novo Nordisk
Oct 15, 2025, 04:00 ET Amrop Expands Global Presence with New Office in Poland
2025 /PRNewswire/ -- Amrop, a leading global executive search and leadership advisory partnership, is pleased to announce the appointment of dk Executive Search as its new team in Poland. This strategic expansion reinforces Amrop's commitment to strengthening its footprint across key European
More news about: Amrop
Oct 15, 2025, 04:00 ET Amrop erweitert globale Präsenz mit neuer Niederlassung in Polen
/PRNewswire/ -- Amrop, eine weltweit führende Partnerschaft für die Suche nach Führungskräften und Führungsberatung, freut sich, die Ernennung von dk Executive Search als neues Team in Polen bekannt zu geben. Diese strategische Expansion unterstreicht das Engagement von Amrop, seine Präsenz in
More news about: Amrop
Oct 15, 2025, 04:00 ET Amrop Expands Global Presence with New Office in Poland
2025 /PRNewswire/ -- Amrop, a leading global executive search and leadership advisory partnership, is pleased to announce the appointment of dk Executive Search as its new team in Poland. This strategic expansion reinforces Amrop's commitment to strengthening its footprint across key European
More news about: Amrop
Oct 15, 2025, 04:00 ET Amrop étend sa présence mondiale avec un nouveau bureau en Pologne
2025 /PRNewswire/ -- Amrop, l'un des leaders mondiaux de la recherche de cadres et du conseil en leadership, a le plaisir d'annoncer la nomination de dk Executive Search, sa nouvelle équipe en Pologne. Cette expansion stratégique renforce l'engagement d'Amrop à consolider sa présence sur les principaux
More news about: Amrop
Sep 24, 2025, 11:13 ET Children's Hospital of Philadelphia Researchers Find Combination of Diet and Medication Reprograms Fatal Childhood Tumors
cancer that have frequent MYC gene activation. This work was supported by the US National Institutes of Health (NIH Pioneer award (452DP1DK113643) and (R01CA163591). The work was also supported by NIH grant (R50CA211437), grants from the NOMIS Foundation, Holcim-Stiftung Wissen, Gertrud-Hagmann-Stiftung
More news about: Children's Hospital of Philadelphia
Sep 04, 2025, 10:10 ET DMEC: Mapping the ocean environment to develop offshore renewable energy programs
EOMAP GmbH & Co. KG (DE), Crestwing (DK), ORPC (CA/IE), the consortium brings together world-class expertise in EO analytics, offshore
More news about: DMEC; City of The Hague
Sep 03, 2025, 09:00 ET Bazooka Joe® Enters the Big Leagues with All-Star Athlete Comic Collaboration
Bazooka Joe welcomes 12 sports icons including Jason Kelce (former Philadelphia Eagles), DK Metcalf (Pittsburgh Steelers), and Karl-Anthony Towns (New York Knicks), into the Bazookaverse® in a new limited-edition collector
More news about: Bazooka Brands
Aug 26, 2025, 04:00 ET Jacobs Supports Landmark Marselis Tunnel Project in Denmark
are no similar projects like this that have been delivered before in Denmark." Rambøll Director of Transport-DK Asger Knudsen said: "Rambøll and our partners are proud and honored to be chosen for this important and complex task.
More news about: Jacobs
Aug 21, 2025, 02:53 ET Aquaporin announces results for first half 2025
Company announcement No. 16/2025 Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngby aquaporin.com Company registration no.: DK28315694 KONGENS LYNGBY, Denmark,
More news about: Aquaporin A/S
Aug 21, 2025, 02:49 ET Aquaporin announces results for first half 2025
Company announcement No. 16/2025 Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngby aquaporin.com Company registration no.: DK28315694 KONGENS LYNGBY, Denmark,
More news about: Aquaporin A/S
Aug 15, 2025, 15:54 ET Children's Hospital of Philadelphia and Children's Hospital Colorado Researchers Conduct First Prospective Study of Pediatric EoE Patients and Disease Progression
disease and could benefit from a variety of treatment strategies. This study was supported by the National Institutes of Health grants R01DK124266-01, K23DK109263 and R21TR003039. Kennedy et al, "Histologic response is associated with improved esophageal distensibility and symptom burden in
More news about: Children's Hospital of Philadelphia and Children's Hospital Colorado
Aug 12, 2025, 20:08 ET OIKOS® Launches First-of-Its-Kind Cultured Dairy Drink Featuring A Patented Blend of Nutrients Designed to Help Build & Retain Muscle Mass During Weight Loss
American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Obesity (Silver Spring). 2025; 1-29. 3 Layman, DK. Role of Leucine in Protein Metabolism During Exercise and Recovery. Can J App Physiol. 2002; 27(6): 646-662.
More news about: Danone USA
Aug 11, 2025, 15:22 ET Aquaporin lowers revenue guidance for 2025, but maintains EBITDA guidance, and initiates strategic review
announcementNo. 15/2025Inside information Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngbyaquaporin.comCompany registration no.: DK28315694 KONGENS LYNGBY, Denmark,
More news about: Aquaporin A/S
Aug 11, 2025, 15:20 ET Aquaporin lowers revenue guidance for 2025, but maintains EBITDA guidance, and initiates strategic review
announcementNo. 15/2025Inside information Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngbyaquaporin.comCompany registration no.: DK28315694 KONGENS LYNGBY, Denmark,
More news about: Aquaporin A/S
Aug 07, 2025, 08:30 ET MDU Resources Announces Second Quarter 2025 Results; Updates Guidance
Average cost of natural gas per dk $ 6.42
More news about: MDU Resources Group, Inc.
Jul 22, 2025, 01:37 ET Embla Medical hf: Interim Report Q2 2025
3:00 ET. To actively participate in the telephone conference, please use the dial-in details provided below: DK: +45 78 76 84 90 SE: +46 31-311 50 03 UK: +44 20 3769 6819 US: +1 646 787 0157 Participant access code: 274982 The
More news about: Embla Medical hf.
Jul 22, 2025, 01:34 ET Embla Medical hf: Interim Report Q2 2025
3:00 ET. To actively participate in the telephone conference, please use the dial-in details provided below: DK: +45 78 76 84 90 SE: +46 31-311 50 03 UK: +44 20 3769 6819 US: +1 646 787 0157 Participant access code: 274982 The
More news about: Embla Medical hf.
Jul 11, 2025, 14:06 ET Dr. K.A. Paul, Founder of Global Peace Initiative, Believes a New Political Party Can Lead the US into a New Political Future
https://drive.google.com/file/d/1DK9a3f8bBSwOP8z82ZApe-4pRkYINbBG/view?usp=drivesdk With Elon Musk reportedly ready to spend \$1 billion to support a viable
More news about: Global Peace Initiative
Jul 10, 2025, 10:00 ET SPINDRIFT PARTNERS WITH PATRICOF CO TO WELCOME NEW WAVE OF ATHLETE INVESTORS
Strategic investment includes Kevin Durant, DK Metcalf, Azzi Fudd, Derrick White, Maarten Paes, Sophie Cunningham,
More news about: SPINDRIFT